{"Title": "NF-Y activates genes of metabolic pathways altered in cancer cells", "Year": 2016, "Source": "Oncotarget", "Volume": "7", "Issue": 2, "Art.No": null, "PageStart": 1633, "PageEnd": 1650, "CitedBy": 18, "DOI": "10.18632/oncotarget.6453", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84957612156&origin=inward", "Abstract": "The trimeric transcription factor NF-Y binds to the CCAAT box, an element enriched in promoters of genes overexpressed in tumors. Previous studies on the NF-Y regulome identified the general term metabolism as significantly enriched. We dissect here in detail the targeting of metabolic genes by integrating analysis of NF-Y genomic binding and profilings after inactivation of NF-Y subunits in different cell types. NF-Y controls de novo biosynthetic pathways of lipids, teaming up with the master SREBPs regulators. It activates glycolytic genes, but, surprisingly, is neutral or represses mitochondrial respiratory genes. NF-Y targets the SOCG (Serine, One Carbon, Glycine) and Glutamine pathways, as well as genes involved in the biosynthesis of polyamines and purines. Specific cancer-driving nodes are generally under NF-Y control. Altogether, these data delineate a coherent strategy to promote expression of metabolic genes fuelling anaerobic energy production and other anabolic pathways commonly altered in cancer cells.", "AuthorKeywords": ["Cancer metabolism", "Glycolysis", "NF-Y", "SOCG pathway", "Transcription"], "IndexKeywords": ["CCAAT-Binding Factor", "Cell Line, Tumor", "Gene Expression Profiling", "Gene Expression Regulation, Neoplastic", "HCT116 Cells", "HeLa Cells", "Humans", "Immunoblotting", "K562 Cells", "Metabolic Networks and Pathways", "Models, Genetic", "Neoplasms", "Oligonucleotide Array Sequence Analysis", "Reverse Transcriptase Polymerase Chain Reaction", "RNA Interference"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-84957612156", "SubjectAreas": [["Oncology", "MEDI", "2730"]], "AuthorData": {"23984053500": {"Name": "Benatti P.", "AuthorID": "23984053500", "AffiliationID": "60004591", "AffiliationName": "Dipartimento di Scienze della Vita, Universit\u00e0 di Modena e Reggio Emilia"}, "6603438635": {"Name": "Imbriano C.", "AuthorID": "6603438635", "AffiliationID": "60004591", "AffiliationName": "Dipartimento di Scienze della Vita, Universit\u00e0 di Modena e Reggio Emilia"}, "57104846800": {"Name": "Chiaramonte M.", "AuthorID": "57104846800", "AffiliationID": "60030318", "AffiliationName": "Dipartimento di Bioscienze, Universit\u00e0 degli Studi di Milano"}, "55338657700": {"Name": "Lorenzo M.", "AuthorID": "55338657700", "AffiliationID": "60030318", "AffiliationName": "Dipartimento di Bioscienze, Universit\u00e0 degli Studi di Milano"}, "6603278159": {"Name": "Gnesutta N.", "AuthorID": "6603278159", "AffiliationID": "60030318", "AffiliationName": "Dipartimento di Bioscienze, Universit\u00e0 degli Studi di Milano"}, "57202680258": {"Name": "Mantovani R.", "AuthorID": "57202680258", "AffiliationID": "60030318", "AffiliationName": "Dipartimento di Bioscienze, Universit\u00e0 degli Studi di Milano"}, "23968571000": {"Name": "Dolfini D.", "AuthorID": "23968571000", "AffiliationID": "60030318", "AffiliationName": "Dipartimento di Bioscienze, Universit\u00e0 degli Studi di Milano"}, "35599970900": {"Name": "Hartley J.", "AuthorID": "35599970900", "AffiliationID": "60109234, 60012754, 60022148", "AffiliationName": "Cancer Research UK Drug-DNA Interactions Research Group, UCL Cancer Institute, University College London"}, "6701713285": {"Name": "Hochhauser D.", "AuthorID": "6701713285", "AffiliationID": "60109234, 60012754, 60022148", "AffiliationName": "Cancer Research UK Drug-DNA Interactions Research Group, UCL Cancer Institute, University College London"}}}